Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00111358 · ClinicalTrials.gov registry record · NA
Study of Lifestyle Modification in HIV Lipodystrophy
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00111358: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00111358 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00111358, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study is designed to determine the effects of an intensive lifestyle modification program in patients with HIV and Metabolic Syndrome. The primary endpoints will be improvement in body composition, specifically waist-to-hip ratio (WHR). The secondary endpoints will include improvement of cardiovascular indices, such as total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride cholesterol levels, blood pressure, cardiac enzymes, c-reactive protein (CRP), tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI), and insulin and glucose metabolism. We expect that quality of life indices and life skills should also improve with the lifestyle modification program.
Interventions
- BEHAVIORAL Lifestyle Modification
- OTHER No lifestyle modification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00111358
The ClinicalTrials.gov registry entry for NCT00111358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lifestyle Modification is the first listed.
NCT00111358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00111358 about?
NCT00111358 is a clinical study titled "Study of Lifestyle Modification in HIV Lipodystrophy". This study is designed to determine the effects of an intensive lifestyle modification program in patients with HIV and Metabolic Syndrome. The primary endpoints will be improvement in body composition, specifically waist-to-hip ratio (WHR). The secondary endpoints will include improvement of cardio...
What is the current status of trial NCT00111358?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2003-06. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00111358?
The interventions under investigation include: Lifestyle Modification (BEHAVIORAL), No lifestyle modification (OTHER).
Who is sponsoring clinical trial NCT00111358?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.